M
Marguerite Ennis
Researcher at University of Toronto
Publications - 84
Citations - 6366
Marguerite Ennis is an academic researcher from University of Toronto. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 34, co-authored 75 publications receiving 5838 citations. Previous affiliations of Marguerite Ennis include University Health Network & Mount Sinai Hospital.
Papers
More filters
Journal ArticleDOI
Symptoms associated with malignant wounds: a prospective case series.
TL;DR: The results of this study reflect that malignant wounds are associated with a significant symptomatic burden, and reinforces the need for thorough clinical assessment and evaluation of symptoms.
Journal ArticleDOI
Wounds in advanced illness: a prevalence and incidence study based on a prospective case series
TL;DR: The broad range of wounds along with high rates of prevalence and incidence, reflects that wounds represent a significant management issue for patients with advanced illness and there exists a need for advancement in modalities and measures aimed at risk assessment, prevention and appropriate goal‐oriented management.
Journal ArticleDOI
Blood levels of vitamin D and early stage breast cancer prognosis: a systematic review and meta-analysis.
TL;DR: These findings support an association of low levels of vitamin D with increased risk of recurrence and death in early stage breast cancer patients, and it cannot be concluded that this association is causal.
Journal ArticleDOI
Serum lipids and outcome of early-stage breast cancer: results of a prospective cohort study.
Mala Bahl,Marguerite Ennis,Ian F. Tannock,Jan Hux,Kathleen I. Pritchard,Kathleen I. Pritchard,Jarley Koo,Jarley Koo,Pamela J. Goodwin,Pamela J. Goodwin +9 more
TL;DR: Whether serum levels of total cholesterol (TC) and triglycerides (TG) influence breast cancer outcome is examined, and a trend towards risk of recurrence was seen with higher TC in multivariate analysis.
Journal ArticleDOI
Influence of young age at diagnosis and family history of breast or ovarian cancer on breast cancer outcomes in a population-based cohort study
Jane C. Figueiredo,Jane C. Figueiredo,Marguerite Ennis,Julia A. Knight,Julia A. Knight,John R. McLaughlin,John R. McLaughlin,John R. McLaughlin,Nicky Hood,Frances P. O'Malley,Frances P. O'Malley,Irene L. Andrulis,Irene L. Andrulis,Irene L. Andrulis,Pamela J. Goodwin,Pamela J. Goodwin +15 more
TL;DR: Women diagnosed with BC at age ≤35 have more aggressive tumors; these adverse tumor characteristics, rather than age, lead to poor outcomes, which are restricted to younger women with hormone responsive BC.